HLA-DMB gene and HLA-DRA promoter region polymorphisms in Australian multiple sclerosis patients

Human Immunology

Volumn 60, Issue 9, 1999, Pages 886-893

  Bennetts, Bruce H ^a   Teutsch, Suzy M ^a   Buhler, Marc McW ^a   Heard, Robert N S ^a   Stewart, Graeme J ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

Association; HLA DMB; HLA DRA promoter; Multiple sclerosis; Susceptibility

Indexed keywords

HLA ANTIGEN; HLA DR ANTIGEN; HLA DR1 ANTIGEN;

ALLELISM; ARTICLE; AUSTRALIA; CONTROLLED STUDY; GENE FREQUENCY; GENE LOCUS; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HLA SYSTEM; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROMOTER REGION;

AUSTRALIA; EPISTASIS, GENETIC; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-D ANTIGENS; HLA-DR ANTIGENS; HUMANS; MULTIPLE SCLEROSIS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS);

EID: 0032828827     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(99)00054-3     Document Type: Article

References (40)

1. Ebers G.C., Sadovnick A.D. The role of genetic factors in multiple sclerosis susceptibility. J Neuroimmunol. 54:1994;1.
2. Sadovnick A.D., Baird P.A., Ward R.H. Multiple sclerosis updated risks for relatives . Am J Med Genet. 29:1988;533.
3. Ebers G.C., Sadovnick A.D., Risch N.J. A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group. Nature. 377:1995;150.
4. Ebers G.C., Kukay K., Bulman D.E., Sadovnick A.D., Rice G., Anderson C., Armstrong H., Cousin K., Bell R.B., Hader W., Paty D.W., Hashimoto S., Oger J., Duquette P., Warren S., Gray T., O'Connor P., Nath A., Auty A., Metz L., Francis G., Paulseth J.E., Murray T.J., Pryse-Phillips W., Nelson R., Freedman M., Brunet D., Bouchard J.-P., Hinds D., Risch N. A full genome search in multiple sclerosis. Nature Genet. 13:1996;472.
5. Sawcer S., Jones H.B., Feakes R., Gray J., Smaldon, Chataway J., Robertson N., Clayton D., Goodfellow P.N., Compston A. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nature Genet. 13:1996;464.
6. Haines J., Pericak-Vance M., Seboun E., Hauser S. A complete genome screen for multiple sclerosis underscores a role for the major histocompatability complex. Nature Genet. 13:1996;469.
7. Haines J.L., Terwedow H.A., Burgess K., Pericak-Vance M.A., Rimmler J.B., Martin E.R., Oksenberg J.R., Lincoln R., Zhang D.Y., Banatao D.R., Gatto N., Goodkin D.E., Hauser S.L. Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group. Hum Mol Genet. 7:1998;1229.
8. Jersild C., Dupont B., Fog T., Platz P.J., Svejgaard A. Histocompatibility determinants in multiple sclerosis. Transplant Rev. 22:1975;148.
9. Stewart G.J., Basten A., Guinan J., Bashir H.V., Cameron J., McLeod J.G. HLA-DW2, viral immunity and family studies in multiple sclerosis. J Neurol Sci. 32:1977;153.
10. Stewart G.J., Teutsch S.M., Castle M., Heard R.N.S., Bennetts B.H. HLA-DR, -DQA1 and DQB1 in Australian multiple sclerosis patients. Eur J Immunogenet. 24:1997;81.
11. Bennetts B.H., Teutsch S.M., Heard R.N.S., Dunckley H., Stewart G.J. TAP2 polymorphisms in Australian multiple sclerosis patients. J Neuroimmunol. 59:1995;113.
12. Carrington M., Yeager M., Mann D. Characterization of HLA-DMB polymorphism. Immunogenetics. 38:1993;446.
13. Sanderson F., Powis S.H., Kelly A.P., Trowsdale J. Limited polymorphism in HLA-DM does not involve the peptide binding groove. Immunogenetics. 39:1994;56.
14. Djilali-Saiah I., Benini V., Daniel S., Assan R., Bach J.-F., Caillat-Zucman S. Linkage disequilibrium between HLA class II (DR, DQ, DP) and antigen processing (LMP, TAP, DM) genes of the major histocompatibility complex. Tissue Antigens. 48:1996;87.
15. Naruse T.K., Kawata H., Ishihara M., Ando A., Kagiya M., Nose Y., Isshiki G., Inoko H. Analysis on allelic variation of the HLA-DMB gene in Japanese by PCR-RFLP as well as direct DNA sequencing and identification of a new DMB allele, DMB*0105. Tissue Antigens. 47:1996;530.
16. Panitch H.S., Hirsch R.L., Haley A.S., Johnson K.P. Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet. 1:(8583):1987;893.
17. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double blinded, placebo-controlled trail. II. MRI analysis results of a multicenter, randomized, double blinded, placebo-controlled trail. Neurology. 43:1993;655.
18. Pinet V., Eliou J.-F., Clot J. Description of a polymorphism in the regulatory region of the HLA-DRA gene. Hum Immunol. 32:1991;162.
19. Louis P., Vincent R., Cavadore P., Clot J., Eliaou J.-F. Differential transcriptional activities of HLA-DR genes in the various haplotypes. J Immunol. 153:1994;5059.
20. Andersen L.C., Beaty J.S., Nettles J.W., Seyfried C.E., Nepom G.T., Nepom B.S. Allelic polymorphism in transcriptional regulatory regions of HLA-DQb genes. J Exp Med. 173:1991;181.
21. Yao Z., Kimura A., Hartung K., Haas P.J., Volgger A., Brunnler G., Boonisch J., Albert E.D. Polymorphism of the DQA1 promoter region (QAP) and DRB1, QAP, DQA1, DQB1 haplotypes in systemic lupus erythematous. SLE study group members. Immunogenetics. 38:1993;421.
22. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., Tourtellote W.W. New diagnostic criteria for multiple sclerosis. Guidelines for research protocols. Ann Neurol. 13:1983;227.
23. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis an expanded disability status scale (EDSS) . Neurology. 33:1983;1444.
24. Teutsch S.M., Bennetts B.H., Castle M., Hibbins M., Heard R.N.S., Stewart G.J. HLA-DQA1 and -DQB1 genotyping by PCR-RFLP, heteroduplex and homoduplex analysis. Eur J Immunogenet. 23:1996;107.
25. Lahiri D.K., Nurnberger J.I. Jr. A rapid and non-enzymatic method for the preparation of HMW DNA for RFLP studies. Nucleic Acids Res. 19:1991;5444.
26. Tiwari J.L., Terasaki P.I. The data and statistical analysis. Tiwari J.L., Terasaki P.I. HLA and Disease Associations. 1985;Springer-Verlag, New York.
27. Svejgaard A, Hauge M, Jersild C, Platz P, Ryder LP, Staub-Nielsen L, Thomsen M: The HLA system. Monogr Hum Genet 7.
28. Ristori G., Carcassi C., Lai S., Fiori P., Cacciani A., Floris L., Montesperelli C., Di Giovanni S., Buttinelli C., Contu L., Pozzilli C., Salvetti M. HLA-DM polymorphisms do not associate with multiple sclerosis an association study with analysis of myelin basic protein T cell specificity . J Neuroimmunol. 77:1997;181.
29. Morris P., Shaman J., Attaya M., Amaya M., Goodman S., Bergman C., Monaco J.J., Mellins E. An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature. 368:1994;551.
30. Fling S.P., Arp B., Pious D. HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells. Nature. 368:1994;554.
31. Sanderson F., Kleijmeer M.J., Kelly A., Verwoerd D., Tulp A., Neefjes J.J., Geuze H.J., Trowsdale J. Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments. Science. 266:1994;1566.
32. Robbins N.F., Hammond C., Denzin L.K., Pan M., Cresswell P. Trafficking of major histocompatibility complex class II molecules through intracellular compartments containing HLA-DM. Hum Immunol. 45:1996;13.
33. Sanderson F., Trowsdale J. Kissing cousins exchange CLIP. Curr Biol. 5:1995;1372.
34. Klitz W., Stephens J.C., Grote M., Carrington M. Discordant patterns of linkage disequilibrium of the peptide-transporter loci within the HLA class II region. Am J Hum Genet. 57:1995;1436.
35. Dyment D.A., Sadnovich A.D., Ebers G.C. Genetics of multiple sclerosis. Hum Mol Genet. 6:1997;1693.
36. Hockertz M.K., Paty D.W., Beall S.S. Susceptibility to relapsing-progressive multiple sclerosis is associated with inheritance of genes linked to the variable region of the TcR beta locus use of affected family-based controls . Am J Hum Genet. 62:1998;373.
37. Kellar-Wood H.F., Wood N.W., Holmans P., Clayton D., Robertson N., Compston D.A.S. Multiple sclerosis and the HLA-D region linkage and association studies . J Neuroimmunol. 58:1995;183.
38. Beall S., Concannon P., Charmley P., et al. The germline repertoire of T cell receptor B-chain genes in patients with chronic progressive multiple sclerosis. J Neuroimmunol. 21:1989;59.
39. Seboun E., Robinson M.A., Doolittle T.H., Ciulla T.A., Kindt T.J., Hauser S.L. A susceptibility locus for multiple sclerosis is linked to the T cell receptor beta chain complex. Cell. 57:1989;1095.
40. Martinez-Naves E., Victoria-Gutierrez M., Uria D.F., Lopez-Larrea C. The germline repertoire of T cell B chain genes in multiple sclerosis patients from Spain. J Neuroimmunol. 47:1993;9.